• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Quality

    US FDA sends warning letter to Cardinal Health for marketing unapproved devices

    REUTERS

    FDA warns against using Cardinal`s syringes

    REUTERS

    FDA advises not to purchase certain eye drops due to infection risk

    REUTERS

    FDA slaps Class I label on recall of contaminated ultrasound gel

    FIERCEBIOTECH

    UPDATE 1-Cardinal Health warns ongoing opioid-related lawsuits to hit business

    CNBC

    Valsartan products not currently recalled - Updated August 8, 2018

    FDA

    Database analysis confirms more complications with artery-sealing device

    REUTERS

    Cardinal Health, Ongoing Class III recall of Potassium Chloride, microencapsulated extended-release tablets, 20 mEq, blister card of 30/10 cards in a corrugated shipper, Rx only, Manufactured by Upsher-Smith Laboratories, Inc. Minneapolis, MN 55447 for Sandoz, Inc., Princeton, NJ 08540 Repackaged by Cardinal Health Zanesville, OH 43701 because of Labeling: Incorrect or Missing Package Insert: the package insert for the potassium chloride 8 mEq and 10 mEq strength instead of the potassium chloride 10 mEq and 20 mEq strength was packaged with the product.

    FDA

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.